APDN - アプライドDNAサイエンシス (Applied DNA Sciences Inc) アプライドDNAサイエンシス

 APDNのチャート


 APDNの企業情報

symbol APDN
会社名 Applied DNA Sciences Inc (アプライドDNAサイエンシス)
分野(sector) Consumer Services   消費者サービス
産業(industry) Other Consumer Services  
業種 化学_特殊化学製品   工業(Industrials)
概要 事業概要 Applied DNA Sciences Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA SigNature T DNA fiberTyping DNAnet digitalDNA SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company''s platform ingredient at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.   アプライドDNAサイエンシスは、米国のDNAセキュリティ―ソリュ―ション会社。製品、ブランド、知的財産権の偽造や転用を防ぐため、北米と欧州で、DNAタグを利用した偽造防止技術を供給する。主な製品は、「SigNatureDNA」、「fiberTyping」、「 DNANet」、 「digitalDNA」など。本社は、ニューヨーク州スト―ニ―ブルック。   
本社所在地 50 Health Sciences Drive Stony Brook NY 11790 USA
代表者氏名 James A. Hayward ジェームズ・A・ヘイワード
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 631-240-8800
設立年月日 1983年
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 60人
url www.adnas.com
nasdaq_url https://www.nasdaq.com/symbol/apdn
adr_tso
EBITDA EBITDA(百万ドル) -10.19729
終値(lastsale) 1.42
時価総額(marketcap) 42759120.94
時価総額 時価総額(百万ドル) 43.36136
売上高 売上高(百万ドル) 3.85349
企業価値(EV) 企業価値(EV)(百万ドル) 40.84654
当期純利益 当期純利益(百万ドル) -11.07232
決算概要 決算概要 BRIEF: For the nine months ended 30 June 2018 Applied DNA Sciences Inc revenues decreased 25% to $2.7M. Net loss decreased 18% to $8.2M. Revenues reflect United States (Country) segment decrease of 58% to $1.1M Europe segment decrease of 17% to $799K. Lower net loss reflects Selling general and administrative decrease of 29% to $7.5M (expense) Depreciation and amortization decrease of 13% to $426K (expense).

 APDNのテクニカル分析


 APDNのニュース

   Earnings Preview for Applied DNA Sciences  2021/02/10 15:43:00 Yahoo Finance
Applied DNA Sciences (NASDAQ:APDN) announces its next round of earnings this Thursday, February 11. Here is Benzinga's look at Applied DNA Sciences's Q1 earnings report. Net Income, Earnings, And Earnings Per Share Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding. Earnings And Revenue Based on management's projections, Applied DNA Sciences analysts modeled for a loss of $0.54 per share on sales of $1.36 million. Applied DNA Sciences EPS in the same period a year ago totaled $1.12. Revenue was $633.52 thousand. Why Analyst Estimates And Earnings Surprises Are Important Wall Street analysts who study this company will publish analyst estimates of revenue and EPS. The averages of all analyst EPS and revenue estimates are called the "consensus estimates"; these consensus estimates can have a significant effect on a company's performance during an earnings release.
   Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021  2021/02/05 12:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) announced today that it will report fiscal 2021 first quarter financial results after market close on Thursday, February 11, 2021. The Company’s management will discuss the results during a conference call and simultaneous webcast at 4:30 p.m. ET that same day. Presentation slides will also be posted to the ‘IR Calendar’ section of the Company’s corporate website and embedded into the live webcast. Conference Call and
   Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution  2021/01/26 13:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the signing of a definitive agreement with TruTrace Technologies, Inc. (CSE: TTT) (“TruTrace”), developer of a fully-integrated blockchain platform for the legal cannabis, food and pharmaceutical industries, to approach the cannabis industry with an integrated solution comprised of Applied DNA’s CertainT® platform and
   Applied DNA Promotes Judith Murrah to Chief Operating Officer  2021/01/20 12:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the promotion of Chief Information Officer Judith Murrah to the role of Chief Operating Officer effective immediately. The promotion formalizes Ms. Murrah’s expanding range of responsibilities that includes the development of key customer and partner relationships, QA oversight, and operations management. Ms. Murrah h
   Applied DNA Linea™ COVID-19 Assay Kit Demonstrates Effectiveness with Detection of Multiple SARS-CoV-2 Variants During Recent Surveillance Testing  2021/01/19 12:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Linea™ COVID-19 Assay Kit (the “Assay Kit”) identified COVID-19 positive samples that are variants distinct from the wild-type virus that has dominated the U.S. in the pandemic until now. The variants were identified as part of the Company’s safeCircleTM pooled surveillance testing service, which is powered b
   Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution  2021/01/26 13:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the signing of a definitive agreement with TruTrace Technologies, Inc. (CSE: TTT) (“TruTrace”), developer of a fully-integrated blockchain platform for the legal cannabis, food and pharmaceutical industries, to approach the cannabis industry with an integrated solution comprised of Applied DNA’s CertainT® platform and
   Applied DNA Promotes Judith Murrah to Chief Operating Officer  2021/01/20 12:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the promotion of Chief Information Officer Judith Murrah to the role of Chief Operating Officer effective immediately. The promotion formalizes Ms. Murrah’s expanding range of responsibilities that includes the development of key customer and partner relationships, QA oversight, and operations management. Ms. Murrah h
   Applied DNA Linea™ COVID-19 Assay Kit Demonstrates Effectiveness with Detection of Multiple SARS-CoV-2 Variants During Recent Surveillance Testing  2021/01/19 12:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Linea™ COVID-19 Assay Kit (the “Assay Kit”) identified COVID-19 positive samples that are variants distinct from the wild-type virus that has dominated the U.S. in the pandemic until now. The variants were identified as part of the Company’s safeCircleTM pooled surveillance testing service, which is powered b
   Why Applied DNA Sciences Is Up 30% Today  2021/01/15 19:53:14 Benzinga
Applied DNA Sciences (NASDAQ: APDN ) shares are trading higher on reports the U.K. COVID strain could become the dominant strain in the U.S. The FDA last week reported the company's test is … Full story available on Benzinga.com
   Applied DNA Provides Business Update on COVID-19 Diagnostics and Testing  2021/01/15 12:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its safeCircle™ pooled surveillance testing service has seen a 158% increase in the daily average number of tests performed to date in January 2021 compared to December 2020. The increase is chiefly the result of the scale-up of certain testing contracts and from the acquisition of new clients. Launched in the fou
   Applied DNA Reports 2020 Year End and Fiscal Fourth Quarter Financial Results  2020/12/17 21:05:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the full fiscal year and quarter ended September 30, 2020. “Our activities in fiscal 2020 were principally devoted to the establishment of our diagnostic and surveillance testing programs for COVID-19 and to further positioning our proprietary LinearDNA™ manufacturin
   Applied DNA Sciences, Inc. to Host Earnings Call  2020/12/17 19:30:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / December 17, 2020 / Applied DNA Sciences, Inc.
   Applied DNA Awarded Pooled Surveillance Testing Contract Valued at Up to $2.0 Million from Suffolk County (N.Y.) Government  2020/12/17 18:10:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC (ADCL), has secured a safeCircle™ pooled COVID-19 surveillance testing program (the “Program”) award with a potential value of up to $2.0 million from the Suffolk County (N.Y.) Government (the “County”). The 6-month term and awar
   Applied DNA Sciences Earnings Preview  2020/12/16 10:02:00 Benzinga
Applied DNA Sciences (NASDAQ:APDN) announces its next round of earnings this Thursday, December 17. Here is Benzinga's everything-that-matters guide for …
   Compliance with New York State Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program  2020/12/11 13:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that its Applied DNA Clinical Laboratories, LLC (ADCL) subsidiary is experiencing growing demand for its safeCircle™ pooled COVID-19 surveillance testing program that is being primarily driven by New York State (the “State”) schools moving to comply with the State’s Winter COVID-19 Plan (the “Plan”) that al

 関連キーワード  (化学_特殊化学製品 米国株 アプライドDNAサイエンシス APDN Applied DNA Sciences Inc)

化学産業により作られた製品は、経済の基盤を成し自動車や電機産業のほか、日用雑貨や医薬品など生活の隅々で使用されている。化学産業は経済活動の影響を受ける面が大きく、関連株も景気動向に左右される。化学産業の基礎資材は石油から作られ原油価格の影響も受けやすい。また、日本の化学産業はアジアなど海外企業との競争も激しくなっている。

 twitter  (公式ツイッターやCEOツイッターなど)